Cellectar Biosciences, Inc. (CLRB) Form 424B3 — Jun 2, 2026
Cellectar Biosciences (CLRB) filed a prospectus registering the resale of up to 51,998,413 shares of common stock by selling stockholders. These shares originate from a private placement and registered direct offering closed in May 2026, including pre-funded warrants and series A, B, and C warrants exercisable at $2.65 per share. The company will not receive any proceeds from the resale of these shares by the selling stockholders, creating significant potential dilution for existing holders. The registered shares represent approximately 1,226% of the 4.24 million shares outstanding prior to the recent capital raise.
Key figures
- Cash Position
- 13200000
- Offering Price
- 2.65
- Shares Offered
- 51998413
- Shares Outstanding
- 4240129
- Rdo shares issued
- 1618053
- Last reported price
- 3.14
- Series a warrants shares
- 13206026
- Series b warrants shares
- 13206026
- Series c warrants shares
- 13206026
- Pre funded warrants shares
- 9471086
- Placement agent fee percent
- 8
- Placement agent warrants shares
- 792362
- Placement agent expense reimbursement
- 110000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.